Tudor Investment Corp’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-82,089
Closed -$3.33M 3711
2025
Q4
$3.33M Sell
82,089
-42,855
-34% -$1.86M 0.01% 1431
2025
Q3
$5.88M Buy
124,944
+83,418
+201% +$4.32M 0.01% 1085
2025
Q2
$2.16M Buy
+41,526
New +$2.28M ﹤0.01% 1612
2024
Q4
Sell
-49,285
Closed -$3.54M 3075
2024
Q3
$3.54M Sell
49,285
-59,036
-55% -$4.17M 0.01% 888
2024
Q2
$7.51M Sell
108,321
-5,110
-5% -$373K 0.04% 489
2024
Q1
$9.08M Buy
113,431
+36,187
+47% +$3.23M 0.06% 389
2023
Q4
$8.46M Sell
77,244
-1,182
-2% -$122K 0.07% 402
2023
Q3
$7.91M Buy
78,426
+62,677
+398% +$7.2M 0.08% 315
2023
Q2
$2.14M Sell
15,749
-48,726
-76% -$5.95M 0.03% 864
2023
Q1
$6.7M Buy
64,475
+11,274
+21% +$1.09M 0.1% 257
2022
Q4
$4.72M Sell
53,201
-28,573
-35% -$2.37M 0.09% 271
2022
Q3
$6.56M Buy
81,774
+8,944
+12% +$844K 0.14% 150
2022
Q2
$6.97M Buy
72,830
+47,650
+189% +$5.72M 0.18% 107
2022
Q1
$3.74M Buy
+25,180
New +$3.52M 0.09% 286
2020
Q4
Sell
-4,511
Closed -$355K 1367
2020
Q3
$355K Sell
4,511
-12,351
-73% -$1.01M 0.02% 935
2020
Q2
$1.21M Sell
16,862
-7,650
-31% -$532K 0.06% 419
2020
Q1
$1.4M Buy
24,512
+14,432
+143% +$1.33M 0.13% 164
2019
Q4
$1.13M Buy
10,080
+4,721
+88% +$503K 0.05% 462
2019
Q3
$515K Buy
+5,359
New +$503K 0.02% 702
2016
Q1
Sell
-5,000
Closed -$220K 1773
2015
Q4
$220K Sell
5,000
-1,500
-23% -$65.1K 0.01% 1402
2015
Q3
$310K Buy
+6,500
New +$357K 0.01% 1084
2015
Q1
Sell
-8,180
Closed -$368K 1466
2014
Q4
$368K Sell
8,180
-16,462
-67% -$690K 0.01% 921
2014
Q3
$908K Buy
24,642
+2,272
+10% +$90.1K 0.03% 336
2014
Q2
$988K Sell
22,370
-2,553
-10% -$116K 0.04% 210
2014
Q1
$1.08M Buy
24,923
+17,623
+241% +$785K 0.05% 179
2013
Q4
$310K Sell
7,300
-3,800
-34% -$144K 0.02% 869
2013
Q3
$377K Sell
11,100
-16,700
-60% -$545K 0.02% 478
2013
Q2
$868K Buy
+27,800
New +$902K 0.07% 146

Other funds holding CNMD

Tudor Investment Corp's CNMD Position: Q1 2026 in Review

Tudor Investment Corp sold out of CONMED (CNMD) in Q1 2026, closing a stake of 82,089 shares — an estimated $3.33M sold.

Tudor Investment Corp first reported a position in CNMD in Q2 2013 and held it in 28 quarters. The position peaked at $9.08M in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Tudor Investment Corp reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 82,089 CONMED shares in Q1 2026, an estimated $3.33M.
  • Tudor Investment Corp first reported a position in CONMED in Q2 2013 and held it in 28 quarters.
  • Tudor Investment Corp's CONMED position peaked at $9.08M in Q1 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.